Bharat Biotech's intranasal Covid vaccine approved by govt, to be available on CO-WIN

Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening, they said.

The nasal vaccine -- BBV154 -- received approval of the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18 as a heterologous booster dose.

The approval for the vaccine comes amid a spurt in Covid cases in China and some other countries.

Prime Minister Narendra Modi had on Thursday cautioned people against complacency and urged them to wear masks in crowded places, while also directing officials to strengthen surveillance measures, especially at international airports.

SEE ALSO:

Police officers were seen guarding a crematorium in Beijing amid reports of overflowing funeral homes due to a resurgence in COVID infections: Bloomberg

PM Modi to review Covid-19 situation at high-level meeting today

3 cases of Omicron subvariant BF.7, driving China's Covid surge, detected in India